Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 1,040

The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.

Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo

Hughes, David E., Wright, Kenneth R., Uy, Harry L., Sasaki, Akira, Yoneda, Toshiyuki, Roodman, David G., Mundy, Gregory R., Dr. Boyce, Brendan F. · 1995 · Journal of Bone and Mineral Research

Abstract

Bisphosphonates inhibit bone resorption and are therapeutically effective in diseases of increased bone turnover, such as Paget's disease and hypercalcemia of malignancy. The mechanisms by which they act remain unclear. Proposed mechanisms include inhibition of osteoclast formation from precursors and inhibitory or toxic effects on mature osteoclasts. We have developed a new in vitro model to study osteoclast survival and in this paper present in vitro and in vivo evidence that may explain both the observed reduction in osteoclast numbers and in bone resorption by mature osteoclasts, namely that bisphosphonates induce programmed cell death (apoptosis). Three bisphosphonates (risedronate, pamidronate, and clodronate) caused a 4- to 24-fold increase in the proportion of osteoclasts showing the characteristic morphology of apoptosis in vitro. This observation was confirmed in vivo in normal mice, in mice with increased bone resorption, and in nude mice with osteolytic cancer metastases, with similar-fold increases to those observed in vitro. Of the three compounds, risedronate, the most potent inhibitor of bone resorption in vivo, was the strongest inducer of osteoclast apoptosis in vitro. Osteoclast apoptosis may therefore be a major mechanism whereby bisphosphonates reduce osteoclast numbers and activity, and induction of apoptosis could be a therapeutic goal for new antiosteoclast drugs.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/jbmr.5650101008

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 6

  1. Fleisch, 1993, Prospective use of bisphosphonates in osteoporosis, J Clin Endocrinol Metab, 76, 1397
  2. Sasaki, 1989, Multinucleated cells formed on calcified dentine from mouse bone marrow cells treated with 1,25-dihydroxyvitamin D3 have ruffled borders and resorb bone, Anat Rec, 224, 379, 10.1002/ar.1092240307 · doi:10.1002/ar.1092240307
  3. Fouda, 1989, Developmental disturbances of the rat molar induced by two diphosphonates, Adv Dent Res, 3, 234, 10.1177/08959374890030022401 · doi:10.1177/08959374890030022401
  4. Uy, 1994, Risedronate affects mature osteoclasts (ocl) but not ocl precursors in vivo, J Bone Miner Res, 9, S242
  5. Pioli, 1990, Bisphosphonates stimulate the production of cytokines by human peripheral blood mononuclear cells in vitro, Calcif Tissue Int, 46, A54
  6. Hughes, 1994, TGFβ1 induces osteoclast apoptosis in vitro, J Bone Miner Res, 9, S138

Cited by

See all 1,040

Metadata

Authors
Hughes, D. E., Wright, K. R., Uy, H. L., Sasaki, A., Yoneda, T., Roodman, D. G., Mundy, G. R., & Dr. Boyce, B. F.
Venue
Journal of Bone and Mineral Research
Published
1995-10-01
Volume
10
Issue
10
Pages
1478-1487
ISSN
  • 0884-0431 (ISSN-L)
  • 1523-4681
OpenAlex
W2161690532
Cited by
1,040
References
49
FWCI
10.54
Type
journal article
Language
en
Open access
closed
Funders
  • NIH (DE 08569, CA 40035, AR-41336)
  • American Cancer Society (IRG-116)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.